Researchers at UC San Diego have found a paradoxical new way in which cancer cells survive and regrow after targeted therapy: by hijacking a protein involved in cell death.
Antibiotic resistance is one of the most pressing challenges to global public health as harmful microbes evolve to evade these medications. Now, researchers at University of California San Diego and their colleagues have developed a new method to combat antibiotic-resistant bacteria
The San Diego Robotics Forum celebrated its 10th anniversary Nov. 5, 2025 with talks from startup founders who are also alumni, entrepreneur guest speakers, and engineering faculty whose work probes the limits of what is possible in robotics and artificial intelligence.
UC San Diego has once again been recognized among the top institutions in the world on the 2025 Highly Cited Researchers list compiled by Clarivate. UC San Diego tied for 18th in the world this year with UCLA. Both schools have 50 recognitions on the Highly Cited Researchers listing.
Engineers have developed a next-generation wearable system that enables people to control machines using everyday gestures — even while running, riding in a car or floating on turbulent ocean waves.
UC San Diego researchers have developed a new targeted therapy for triple-negative breast cancer, the most difficult-to-treat subtype of the disease.
Keep up with all the latest from UC San Diego. Subscribe to the newsletter today.
